Authors:
MARSTON HM
FINLAYSON K
MAEMOTO T
OLVERMAN HJ
AKAHANE A
SHARKEY J
BUTCHER SP
Citation: Hm. Marston et al., PHARMACOLOGICAL CHARACTERIZATION OF A SIMPLE BEHAVIORAL-RESPONSE MEDIATED SELECTIVELY BY CENTRAL ADENOSINE A(1) RECEPTORS, USING IN-VIVO AND IN-VITRO TECHNIQUES, The Journal of pharmacology and experimental therapeutics, 285(3), 1998, pp. 1023-1030
Authors:
MEYERS AI
AKAHANE A
STRUZKA V
WARMUS JS
GONZALEZ M
MILOT G
Citation: Ai. Meyers et al., A REINVESTIGATION OF THE REPORTED SYNTHESIS OF THE SPIROBENZYL ISOQUINOLINE ALKALOID, ISO-OCHOTENSINE, Tetrahedron letters, 38(24), 1997, pp. 4195-4198
Authors:
MAEMOTO T
FINLAYSON K
OLVERMAN HJ
AKAHANE A
HORTON RW
BUTCHER SP
Citation: T. Maemoto et al., SPECIES-DIFFERENCES IN BRAIN ADENOSINE A(1) RECEPTOR PHARMACOLOGY REVEALED BY USE OF XANTHINE AND PYRAZOLOPYRIDINE BASED ANTAGONISTS, British Journal of Pharmacology, 122(6), 1997, pp. 1202-1208
Authors:
AKAHANE A
KATAYAMA H
MITSUNAGA T
KITA Y
KUSUNOKI T
TERAI T
YOSHIDA K
SHIOKAWA Y
Citation: A. Akahane et al., DISCOVERY OF FK453, A NOVEL NONXANTHINE ADENOSINE A(1) RECEPTOR ANTAGONIST, Bioorganic & medicinal chemistry letters, 6(17), 1996, pp. 2059-2062
Authors:
TERAI T
KUSUNOKI T
KITA Y
YOSHIDA K
AKAHANE A
SHIOKAWA Y
KOHNO Y
HORIAI H
MORI J
MINE Y
KOHSAKA M
Citation: T. Terai et al., GENERAL PHARMACOLOGY OF THE NEW NONXANTHINE ADENOSINE A(1) RECEPTOR ANTAGONIST PYRAZOLO[1,5-A]PYRIDIN-3-YL)ACRYLOYL]-2-PIPERIDINE ETHANOL()), Arzneimittel-Forschung, 46(2), 1996, pp. 185-191
Authors:
TERAI T
KITA Y
KUSUNOKI T
ANDOH T
NAGATOMI T
HORIAI H
AKAHANE A
SHIOKAWA Y
YOSHIDA K
Citation: T. Terai et al., RENAL EFFECTS OF FK453 - A POTENT NONXANTHINE ADENOSINE A(1) RECEPTORANTAGONIST, Drug development research, 36(1), 1995, pp. 25-34
Authors:
OYASU H
NAGANO M
AKAHANE A
TOMOI M
TADA T
MATSUO M
Citation: H. Oyasu et al., SYNTHESIS AND ANTICHOLINERGIC ACTIVITY OF THE 4 STEREOISOMERS OF -(DIMETHYLAMINO)-2-PHENYL-2-(2-PYRIDYL)PENTANAMIDE, Journal of medicinal chemistry, 37(9), 1994, pp. 1378-1381